These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 6177408

  • 21. Unexpected clinical outcome in a patient with liver and brain metastasis from melanoma.
    Nuzzo C, Zeuli M, Ferraresi V, Ciccarese M, Pelligrini D, Cognetti F.
    Anticancer Res; 2008; 28(2B):1429-31. PubMed ID: 18505091
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S, Camós M, López-Guillermo A, Bosch F, Cervantes F, Blandé J, Esteve J, Cobo F, Nomdedeu B, Campo E, Montserrat E.
    Cancer; 2000 May 01; 88(9):2142-8. PubMed ID: 10813727
    [Abstract] [Full Text] [Related]

  • 26. Probable cure of metastatic testicular tumors treated with sequential therapy.
    Neidhart JA, Memo R, Metz EN, Wise H.
    Cancer Treat Rep; 1980 May 01; 64(4-5):553-8. PubMed ID: 6159075
    [Abstract] [Full Text] [Related]

  • 27. Combination chemotherapy (dacarbazine, carmustine, cisplastin, and tamoxifen) in advanced melanoma.
    Tan EH, Ang PT.
    Singapore Med J; 1996 Apr 01; 37(2):165-7. PubMed ID: 8942255
    [Abstract] [Full Text] [Related]

  • 28. Vinblastine, bleomycin, and cis-platinum for the treatment of metastatic malignant melanoma. National Cancer Institute of Canada Melanoma Group.
    J Clin Oncol; 1984 Feb 01; 2(2):131-4. PubMed ID: 6199480
    [Abstract] [Full Text] [Related]

  • 29. [Chemotherapy of malignant melanoma].
    Ishihara K, Yamazaki N, Asano K.
    Gan To Kagaku Ryoho; 1993 Aug 01; 20(10):1287-92. PubMed ID: 7688498
    [Abstract] [Full Text] [Related]

  • 30. Development and results of biochemotherapy in metastatic melanoma: the University of Texas M.D. Anderson Cancer Center experience.
    Legha SS, Ring S, Eton O, Bedikian A, Plager C, Papadopoulos N.
    Cancer J Sci Am; 1997 Dec 01; 3 Suppl 1():S9-15. PubMed ID: 9457387
    [Abstract] [Full Text] [Related]

  • 31. Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma.
    Kim KB, Eton O, East MJ, Hodges C, Papadopoulos NE, Grimm EA, Bedikian AY.
    Cancer; 2004 Aug 01; 101(3):596-603. PubMed ID: 15274073
    [Abstract] [Full Text] [Related]

  • 32. Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD), and human leukocyte interferon for metastatic uveal melanoma.
    Pyrhönen S, Hahka-Kemppinen M, Muhonen T, Nikkanen V, Eskelin S, Summanen P, Tarkkanen A, Kivelä T.
    Cancer; 2002 Dec 01; 95(11):2366-72. PubMed ID: 12436444
    [Abstract] [Full Text] [Related]

  • 33. Procarbazine, vincristine, CCNU, and cyclophosphamide (POCC) in the treatment of metastatic malignant melanoma.
    Green MR, Dillman RO, Horton C.
    Cancer Treat Rep; 1980 Jan 01; 64(1):139-42. PubMed ID: 7379047
    [Abstract] [Full Text] [Related]

  • 34. [Chemotherapy of malignant melanoma].
    Ishihara K.
    Gan To Kagaku Ryoho; 1995 Jan 01; 22(1):23-7. PubMed ID: 7529980
    [Abstract] [Full Text] [Related]

  • 35. [Treatment of non-seminomatous testicular tumors in combination with vinblastine/bleomycin and adriamycin/cisplatin].
    Boewer C, Fleck H, Uibel M, Nawka S.
    Z Urol Nephrol; 1982 May 01; 75(5):315-23. PubMed ID: 6180571
    [Abstract] [Full Text] [Related]

  • 36. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M, Miyake H, Hara I, Muramaki M, Takenaka A, Fujisawa M.
    Hinyokika Kiyo; 2007 Dec 01; 53(12):851-6. PubMed ID: 18203521
    [Abstract] [Full Text] [Related]

  • 37. Metastatic melanoma: case report of a patient with seventeen months of complete remission, five years survival and review of the literature.
    Samelis GF, Ekmektzoglou KA, Tsiakou A, Konstadoulakis MM.
    J BUON; 2009 Dec 01; 14(4):717-20. PubMed ID: 20148469
    [Abstract] [Full Text] [Related]

  • 38. Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
    Ray-Coquard I, Biron P, Bachelot T, Guastalla JP, Catimel G, Merrouche Y, Droz JP, Chauvin F, Blay JY.
    Cancer; 1998 Jan 01; 82(1):134-40. PubMed ID: 9428489
    [Abstract] [Full Text] [Related]

  • 39. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Jan 01; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 40. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U, Wilke H, Seeber S.
    Semin Oncol; 1996 Oct 01; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.